...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Herb-Drug Interaction: Application of a UPLC-MS/MS Method to Determine the Effect of Polygonum capitatum Extract on the Tissue Distribution and Excretion of Levofloxacin in Rats
【24h】

Herb-Drug Interaction: Application of a UPLC-MS/MS Method to Determine the Effect of Polygonum capitatum Extract on the Tissue Distribution and Excretion of Levofloxacin in Rats

机译:草药 - 药物相互作用:应用UPLC-MS / MS法,以确定多胶质谱系提取物对大鼠左氧氟沙星组织分布和排泄的影响

获取原文
           

摘要

Polygonum capitatum has unique curative effects on the urinary system. In fact, many Polygonum capitatum-based preparations are currently used in the clinic. In China, the combination of levofloxacin (LVFX) with a Chinese herbal preparation derived from Polygonum capitatum has been used for the clinical treatment of urinary system diseases, which can improve the curative effects and reduce the side effects of LVFX. However, the herb-drug interaction (HDI) between these drugs has not been reported and the effect of Polygonum capitatum on the in vivo process of LVFX is unclear. In this article, a sensitive ultraperformance liquid chromatography-tandem mass spectroscopy (UPLC-MS/MS) method was developed to evaluate the effects of the combined application of LVFX and the Polygonum capitatum extract on tissue distribution and excretion. Thereafter, the method was validated for selectivity, accuracy, precision, linearity, lower limit of quantification (LLOQ), dilution integrity, recovery, and matrix effect. Based on tissue distribution, LVFX could diffuse into all of the tested tissues, with significant differences in the content of each tissue between the coadministration group and single administration group. At 48?h after the combination was orally administered, the urinary cumulative excretion of LVFX decreased from 20.69% to 11.84% while its fecal cumulative excretion decreased from 26.08% to 13.28%. Our results suggest that a drug interaction exists between the two drugs in the process of distribution and excretion. This study provides important experimental evidence for further studies on the clinical efficacy and mechanism of the Polygonum capitatum extract and LVFX.
机译:Polygonum Capitatum对泌尿系统具有独特的疗效。事实上,目前在诊所使用许多基于型助致的基质谱系制剂。在中国,左氧氟沙星(LVFX)与来自多粒谱系的中草药制剂的组合已被用于泌尿系统疾病的临床治疗,这可以改善疗效并降低LVFX的副作用。然而,尚未报道这些药物之间的草药 - 药物相互作用(HDI),并且在LVFX的体内过程中的薄饼Capitatum对LVFX的影响尚不清楚。在本文中,开发了一种敏感的超空转液相色谱 - 串联质谱(UPLC-MS / MS)方法,以评估LVFX和Polygonum Capitatum提取物对组织分布和排泄的影响。此后,验证该方法以进行选择性,准确性,精度,线性度,量化下限(LLOQ),稀释完整性,恢复和矩阵效应。基于组织分布,LVFX可以扩散到所有测试组织中,具有共同分子组和单一给药组之间的各组织的含量显着差异。在口服施用组合后48℃,LVFX的尿累积排泄从20.69%降至11.84%,而其粪便累积排泄从26.08%降至13.28%。我们的研究结果表明,两种药物在分布和排泄过程中存在药物相互作用。本研究提供了重要的实验证据,以进一步研究临床疗效和机制的临床疗效和机制提取物和LVFX。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号